Biocartis raised €80M in a funding round in Apr 2017. The company is based in Lausanne, Switzerland. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €80M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
